FDA to Expedite Review of Some Generics

The announced change to its policy on how the agency prioritizes its review of generic drug applications means FDA will expedite the review of generic drug applications until there are three approved generics for a given drug product.

The U.S. Food and Drug Administration implemented a new policy on June 27 to expedite the review of generic drug applications where competition is limited and also published a list of off-patent, off-exclusivity branded drugs without approved generics. These actions are among the first taken under the agency's Drug Competition Action Plan announced by FDA Commissioner Dr. Scott Gottlieb in May 2017. "No patient should be priced out of the medicines they need, and as an agency dedicated to promoting public health, we must do our part to help patients get access to the treatments they require," he said. "Getting safe and effective generic products to market in an efficient way, being risk-based in our own work, and making sure our rules aren't used to create obstacles to new competition can all help make sure that patients have access to more lower-cost options."

To encourage generic drug development, FDA posted a list of branded drugs that have no listed patents or exclusivities and for which the agency has yet to approve a generic drug application and said it will expedite review of any generic drug application for a product on that list to ensure they come to market as quickly as possible. The announced change to its policy on how the agency prioritizes its review of generic drug applications means FDA will expedite the review of generic drug applications until there are three approved generics for a given drug product.

The actions follow FDA's announcement of a public meeting on July 18, 2017, to solicit input on places where its rules are being used in ways that may create obstacles to generic access. "I am committed to continuing to pursue additional policy steps, under the FDA's current authority, to help reduce the burden on patients who have a difficult time paying for the medicines they need," Gottlieb said.

Download Center

HTML - No Current Item Deck
  • Free Safety Management Software Demo

    IndustrySafe Safety Management Software helps organizations to improve safety by providing a comprehensive toolset of software modules to help businesses identify trouble spots; reduce claims, lost days, OSHA fines; and more.

  • Complete Online Safety Training Courses

    Deliver state-of-the art, online safety training courses to your organization with IndustrySafe Training Management Software. Generate reports to track training compliance and automatically notify learners of upcoming or overdue classes.

  • Easy to Use Safety Inspection App

    Conduct inspections on the go with IndustrySafe’s mobile app. Complete safety audits at job sites and remote locations—with or without web access.

  • Track Key Safety Performance Indicators

    IndustrySafe’s Dashboard Module allows organizations to easily track safety KPIs and metrics. Gain increased visibility into your business’ operations and safety data.

  • Analyze Incident Data and Maintain OSHA Compliance

    Collect relevant incident data, analyze trends, and generate accurate regulatory reports, including OSHA 300, 300A, and 301 logs, through IndustrySafe’s extensive incident reporting and investigation module.

  • Industry Safe
comments powered by Disqus